| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |